Crespel A, Ferlazzo E, Franceschetti S, Genton P, Gouider R, Kalviainen R, et al. Unverricht-Lundborg disease. Epileptic Disord. 2016;18:28–37.

Article  PubMed  Google Scholar 

Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, et al. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature. 1997;386:847–51.

Article  CAS  PubMed  Google Scholar 

Joensuu T, Lehesjoki AE, Kopra O. Molecular background of EPM1-Unverricht-Lundborg disease. Epilepsia. 2008;49:557–63.

Article  CAS  PubMed  Google Scholar 

Mancini GM, Schot R, de Wit MC, de Coo RF, Oostenbrink R, Bindels-de Heus K, et al. CSTB null mutation associated with microcephaly, early developmental delay, and severe dyskinesia. Neurology. 2016;86:877–8.

Article  PubMed  Google Scholar 

O’Brien A, Marshall CR, Blaser S, Ray PN, Yoon G. Severe neurodegeneration, progressive cerebral volume loss and diffuse hypomyelination associated with a homozygous frameshift mutation in CSTB. Eur J Hum Genet. 2017;25:775–8.

Article  PubMed  PubMed Central  Google Scholar 

Di Matteo F, Pipicelli F, Kyrousi C, Tovecci I, Penna E, Crispino M, et al. Cystatin B is essential for proliferation and interneuron migration in individuals with EPM1 epilepsy. EMBO Mol Med. 2020;12:e11419.

Article  PubMed  PubMed Central  Google Scholar 

Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, Myers RM. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet. 1998;20:251–8.

Article  CAS  PubMed  Google Scholar 

Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lykken EA, Shyng C, Edwards RJ, Rozenberg A, Gray SJ. Recent progress and considerations for AAV gene therapies targeting the central nervous system. J Neurodev Disord. 2018;10:16.

Article  PubMed  PubMed Central  Google Scholar 

Shannon P, Pennacchio LA, Houseweart MK, Minassian BA, Myers RM. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. J Neuropathol Exp Neurol. 2002;61:1085–91.

Article  PubMed  Google Scholar 

Franceschetti S, Sancini G, Buzzi A, Zucchini S, Paradiso B, Magnaghi G, et al. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol Dis. 2007;25:675–85.

Article  CAS  PubMed  Google Scholar 

Husi H, Fernandes M, Skipworth RJ, Miller J, Cronshaw AD, Fearon KCH, et al. Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers. Biomed Rep. 2019;10:165–74.

CAS  PubMed  PubMed Central  Google Scholar 

Tegelberg S, Kopra O, Joensuu T, Cooper JD, Lehesjoki AE. Early microglial activation precedes neuronal loss in the brain of the Cstb−/− mouse model of progressive myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol. 2012;71:40–53.

Article  CAS  PubMed  Google Scholar 

Sanz P, Serratosa JM. Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities. Expert Rev Mol Med. 2020;22:e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okuneva O, Korber I, Li Z, Tian L, Joensuu T, Kopra O, et al. Abnormal microglial activation in the Cstb(−/−) mouse, a model for progressive myoclonus epilepsy, EPM1. Glia. 2015;63:400–11.

Article  PubMed  Google Scholar 

Okuneva O, Li Z, Korber I, Tegelberg S, Joensuu T, Tian L, et al. Brain inflammation is accompanied by peripheral inflammation in Cstb (−/−) mice, a model for progressive myoclonus epilepsy. J Neuroinflammation. 2016;13:298.

Article  PubMed  PubMed Central  Google Scholar 

Manninen O, Koskenkorva P, Lehtimaki KK, Hypponen J, Kononen M, Laitinen T, et al. White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice. Radiology. 2013;269:232–9.

Article  PubMed  Google Scholar 

Manninen O, Laitinen T, Lehtimaki KK, Tegelberg S, Lehesjoki AE, Grohn O, et al. Progressive volume loss and white matter degeneration in cstb-deficient mice: a diffusion tensor and longitudinal volumetry MRI study. PLoS One. 2014;9:e90709.

Article  PubMed  PubMed Central  Google Scholar 

Sipila JOT, Hypponen J, Kyto V, Kalviainen R. Unverricht-Lundborg disease (EPM1) in Finland: a nationwide population-based study. Neurology. 2020;95:e3117–e23.

Article  PubMed  PubMed Central  Google Scholar 

Norio R, Koskiniemi M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet. 1979;15:382–98.

Article  CAS  PubMed  Google Scholar 

Paulson H. Repeat expansion diseases. Handb Clin Neurol. 2018;147:105–23.

Article  PubMed  PubMed Central  Google Scholar 

Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA. Lafora disease - from pathogenesis to treatment strategies. Nat Rev Neurol. 2018;14:606–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alakurtti K, Weber E, Rinne R, Theil G, de Haan GJ, Lindhout D, et al. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet. 2005;13:208–15.

Article  CAS  PubMed  Google Scholar 

Zerovnik E. Human stefin B: from its structure, folding, and aggregation to its function in health and disease. Front Mol Neurosci. 2022;15:1009976.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kopitar-Jerala N. The role of stefin B in neuro-inflammation. Front Cell Neurosci. 2015;9:458.

Article  PubMed  PubMed Central  Google Scholar 

Penna E, Cerciello A, Chambery A, Russo R, Cernilogar FM, Pedone EM, et al. Cystatin B involvement in synapse physiology of rodent brains and human cerebral organoids. Front Mol Neurosci. 2019;12:195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daura E, Tegelberg S, Yoshihara M, Jackson C, Simonetti F, Aksentjeff K, et al. Cystatin B-deficiency triggers ectopic histone H3 tail cleavage during neurogenesis. Neurobiol Dis. 2021;156:105418.

Article  CAS  PubMed  Google Scholar 

Xu TT, Zeng XW, Wang XH, Yang LX, Luo G, Yu T. Cystatin-B negatively regulates the malignant characteristics of oral squamous cell carcinoma possibly via the epithelium proliferation/differentiation program. Front Oncol. 2021;11:707066.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, Manninen O, et al. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci. 2009;29:5910–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ceru S, Konjar S, Maher K, Repnik U, Krizaj I, Bencina M, et al. Stefin B interacts with histones and cathepsin L in the nucleus. J Biol Chem. 2010;285:10078–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakrabarty P, Rosario A, Cruz P, Siemienski Z, Ceballos-Diaz C, Crosby K, et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One. 2013;8:e67680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hollidge BS, Carroll HB, Qian R, Fuller ML, Giles AR, Mercer AC, et al. Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors. Front Neurol. 2022;13:1051559.

Article  PubMed  PubMed Central  Google Scholar 

Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16:1073–80.

Article  CAS  PubMed  Google Scholar 

Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat. Mol Ther. 2007;15:1504–11.

Article  CAS  PubMed  Google Scholar 

Chew NK, Mir P, Edwards MJ, Cordivari C, Martino D, Schneider SA, et al. The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases. Mov Disord. 2008;23:107–13.

Article  PubMed  Google Scholar 

Magaudda A, Ferlazzo E, Nguyen VH, Genton P. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia. 2006;47:860–6.

Article